Autres langues CNBX Pharmaceuticals Inc.

Actions

CNBX

US13764M2098

Marché Fermé - OTC Markets Autres places de cotation 19:43:40 07/05/2024			Varia. 5j.	Varia. 1 janv.
0,0104 ^USD	+1,47%		-29,25%	-26,76%

16/04	CNBX Pharmaceuticals Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 29 février 2024	CI
12/01	CNBX Pharmaceuticals Inc. annonce ses résultats pour le premier trimestre clos le 30 novembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	16/04
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	12/01
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	30/11
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	14/07/23
BigTime Penny Stocks: Unusual "Chatter" Watchlist (GEGI, AAPJ, CNBX, GTVH)	05/06/23
BigTime Penny Stocks: Potential Breakout Stocks - Watchlist (GNPX, CLNV, CNBX, WOEN)	02/06/23
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/04/23
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	14/04/23
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	08/02/23
CNBX Pharmaceuticals Inc. Announces Board Resignations	08/02/23
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	13/01/23
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	13/01/23
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	29/12/22
Shaul Yemal Resigns Position as Director and Board Member Cnbx Pharmaceuticals Inc	29/12/22
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	30/11/22
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	30/11/22
CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	30/11/22
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma	08/11/22
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.	08/11/22
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy	18/10/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues CNBX Pharmaceuticals Inc.

Actions

CNBX

US13764M2098

Autres langues

Filtres